73441-51-7

Basic information

• Product Name: Benzenemethanamine, N-methyl-4-(1-methylethyl)- (9CI)
• Synonyms: Benzenemethanamine, N-methyl-4-(1-methylethyl)- (9CI);(4-Isopropyl-benzyl)-methyl-amine;1-(4-ISOPROPYLPHENYL)-N-METHYLMETHANAMINE
• CAS NO: 73441-51-7
• Molecular Formula: C₁₁H₁₇N
• Molecular Weight: 163.25938
• Product Categories: ISOPROPYL
• Mol File: 73441-51-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 226.1°C at 760 mmHg
• Flash Point: 86.9°C
• Appearance: /
• Density: 0.901g/cm³
• Vapor Pressure: 0.0833mmHg at 25°C
• Refractive Index: 1.503
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: Benzenemethanamine, N-methyl-4-(1-methylethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, N-methyl-4-(1-methylethyl)- (9CI)(73441-51-7)
• EPA Substance Registry System: Benzenemethanamine, N-methyl-4-(1-methylethyl)- (9CI)(73441-51-7)

Safety Data

• Hazardous Substances Data: 73441-51-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H17N/c1-9(2)11-6-4-10(5-7-11)8-12-3/h4-7,9,12H,8H2,1-3H3

Upstream product

• 73789-86-3 4-i-propylbenzyl bromide 
• 74-89-5 methylamine 
• 122-03-2 (4-isopropylbenzaldehyde) 
• 2051-18-5 4-isopropylbenzyl chloride 
• 6502-22-3 2-isopropylbenzaldehyde 
• 17972-10-0 (4-isopropyl-benzylidene)-methyl-amine 

Downstream Products

• 100607-95-2 dichloro-acetic acid-[(4-isopropyl-benzyl)-methyl-amide] 
• 1187212-41-4 4-((4-isopropylbenzyl)methylamino)benzaldehyde 
• 110932-32-6 N-methyl-N-(4'-isopropylbenzyl)-1-(2-methylnaphthalene)methylamine 

Relevant articles and documents

AZETIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF METABOLIC AND INFLAMMATORY DISEASES

Compounds are disclosed that have a formula represented by the following: These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example inflammatory conditions, infectious diseases, autoimmune diseases, diseases involving impairment of immune cell functions, cardiometabolic diseases, and/or proliferative diseases.

β-lactam derivatives as inhibitors of human cytomegalovirus protease

The development of novel monobactam inhibitors of HCMV protease incorporating a carbon side chain at C-4 and a urea function at N-1 is described. Substitution with small groups at the C-3 position of the β- lactam ring gave an increase in enzymatic activity and in stability; however, a lack of selectivity against other serine proteases was noted. The use of both triand tetrasubstituted urea functionalities gave effective inhibitors of HCMV protease. Benzyl substitution of the urea moiety was beneficial, especially when strong electron-withdrawing groups where attached at the para position. Modest antiviral activity was found in a plaque reduction assay.